NLRP1

We are positioned to develop novel medicines. We are targeting innate immune sensors such as Nod-like receptors (NLRs) that are responsible for numerous Mendelian diseases and more common ailments. Our pioneering track record in this field , access to rare patients and astute scientific expertise are propelling our company’s drug development strategy.